Plasma atrial natriuretic peptide (ANP), a hormone secreted by the heart, is elevated in
cardiac failure. In the aim to study the role of ANP in cardiac failure, the haemodynamic …

We measured atrial natriuretic peptide (ANP) plasma levels in rats with experimental heart
failure caused by left coronary artery ligation. ANP levels were clearly higher in infarcted rats …

Plasma levels of atrial natriuretic peptide (ANP) and renal responses to ANP were examined
in rats with chronic cardiac failure produced by coronary artery ligation and in sham …

Serum levels of atrial natriuretic peptide (ANP) are elevated in chronic heart failure
presumably due to dilatation of the left atrium resulting from increases in intracardiac …

To characterize the systemic and regional vascular effects of atrial natriuretic peptide (ANP)
in chronic heart failure, central hemodynamics, regional blood flow and plasma ANP levels …

In order to study long term changes in plasma atrial natriuretic peptide (ANP) in chronic
heart failure, plasma ANP levels were determined in rats after myocardial infarction due to …

Atrial natriuretic peptide (ANP) is a recently discovered hormone, originating from atrial
myocardium. The peptide (or family of peptides) induces potent diuretic/natiuretic …

Atrial natriuretic peptide (ANP) induces potent diuretic/natriuretic, vasorelaxing and
aldosterone inhibitory effects. Increased plasma levels in congestive heart failure (CHF) …

A short-term treatment of atrial natriuretic peptide (ANP), a circulating hormone of cardiac
origin, is reported to improve cardiac performance in patients with chronic heart failure …

The natriuretic, diuretic, and hypotensive effects of atrial natriuretic peptide (ANP) were
examined in rats 4 wk after myocardial infarction induced by left coronary artery ligation …